| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
H3 histone pseudogene 40 | 0.506 | 0.846 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2005 | 2018 | |||||||||
|
expanded repeat domain, CAG/CTG 1 | 0.736 | 0.154 |
|
disease | 0.370 | None | 0.400 | 7 | 0 | 1999 | 2004 | |||||||||
|
DAOA antisense RNA 1 | 0.729 | 0.154 |
|
disease | 0.350 | None | 1.000 | 6 | 7 | 2003 | 2014 | |||||||||
|
microRNA 137 | 0.513 | 0.846 |
|
disease | 0.350 | None | 0.667 | 6 | 0 | 2012 | 2019 | |||||||||
|
solute carrier family 6 member 4 gene promoter | 0.626 | 0.423 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2000 | 2015 | |||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2018 | |||||||||
|
HLA complex group 9 | 0.700 | 0.500 |
|
disease | 0.310 | None | 1.000 | 3 | 0 | 2012 | 2016 | |||||||||
|
serotonin transporter intronic VNTR enhancer | 0.636 | 0.538 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2003 | 2013 | |||||||||
|
major affective disorder 2 | 0.641 | 0.731 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1995 | 2019 | |||||||||
|
Major depressive disorder | 0.682 | 0.308 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2020 | |||||||||
|
neurofilament light | 0.488 | 0.769 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2004 | 2007 | |||||||||
|
synapsin II | 0.653 | 0.577 |
|
disease | 0.330 | None | 0.500 | 3 | 0 | 2009 | 2016 | |||||||||
|
microRNA 708 | 0.570 | 0.692 |
|
disease | 0.020 | None | 1.000 | 2 | 2 | 2016 | 2017 | |||||||||
|
Major affective disorder 4 | 0.780 | 0.115 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2019 | |||||||||
|
Major affective disorder 6 | 0.780 | 0.115 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2019 | |||||||||
|
TSNAX-DISC1 readthrough (NMD candidate) | 0.729 | 0.154 |
|
disease | 0.320 | None | 1.000 | 2 | 7 | 2010 | 2012 | |||||||||
|
P2RX5-TAX1BP3 readthrough (NMD candidate) | 0.588 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2009 | |||||||||
|
long intergenic non-protein coding RNA 1748 | 0.890 | 0.154 |
|
disease | 0.100 | None | 1.000 | 2 | 5 | 2009 | 2013 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2018 | |||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2001 | 2019 | |||||||||
|
microRNA 212 | 0.535 | 0.808 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2013 | 2016 | |||||||||
|
major affective disorder 1 | 0.743 | 0.269 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2019 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2018 | |||||||||
|
BDNF antisense RNA | 0.638 | 0.538 |
|
disease | 0.020 | None | 1.000 | 2 | 7 | 2015 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 273 | 0.585 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2011 |